Executive Vice President & Chief Financial Officer
Led all financial and human capital aspects of clinical laboratory and anatomic pathology healthcare company with annual revenues in excess of $500 million. PathGroup’s revenues and EBITDA more than doubled since 2017 driven by organic and acquisition-related growth. Led highly successful 2022 equity recap process resulting in 4X return for equity holders..